251 related articles for article (PubMed ID: 35656719)
1. The Efficacy and Safety of Anticoagulants in the Treatment of Cirrhotic Portal Vein Thrombosis: A Systematic Review and Meta-Analysis.
Zhang Z; Zhao Y; Han B; Zhu Z; Sun L; Cui X
Clin Appl Thromb Hemost; 2022; 28():10760296221104797. PubMed ID: 35656719
[TBL] [Abstract][Full Text] [Related]
2. A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis.
Ng CH; Tan DJH; Nistala KRY; Syn N; Xiao J; Tan EXX; Woo FZ; Chew NWS; Huang DQ; Dan YY; Sanyal AJ; Muthiah MD
Hepatol Int; 2021 Oct; 15(5):1196-1206. PubMed ID: 34417718
[TBL] [Abstract][Full Text] [Related]
3. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.
Loffredo L; Pastori D; Farcomeni A; Violi F
Gastroenterology; 2017 Aug; 153(2):480-487.e1. PubMed ID: 28479379
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation therapy early is safe in portal vein thrombosis patients with acute variceal bleeding: a multi-centric randomized controlled trial.
Gao Z; Li S; Zhao J; Li J; Gao Y
Intern Emerg Med; 2023 Mar; 18(2):513-521. PubMed ID: 36692588
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis.
Gao Y; Liu H; Tang F; Zhang X; Li F; Ye Q; Yuan H; Lv H; Han T
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101649. PubMed ID: 33601064
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.
Wang L; Guo X; Xu X; De Stefano V; Plessier A; Noronha Ferreira C; Qi X
Adv Ther; 2021 Jan; 38(1):495-520. PubMed ID: 33155180
[TBL] [Abstract][Full Text] [Related]
7. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
Pettinari I; Vukotic R; Stefanescu H; Pecorelli A; Morelli M; Grigoras C; Sparchez Z; Andreone P; Piscaglia F;
Am J Gastroenterol; 2019 Feb; 114(2):258-266. PubMed ID: 30538290
[TBL] [Abstract][Full Text] [Related]
8. Risk of Bleeding in Liver Cirrhosis Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.
Li Z; Xu W; Wang L; Chai L; Ageno W; Romeiro FG; Li H; Qi X
Thromb Haemost; 2023 Nov; 123(11):1072-1088. PubMed ID: 37336474
[TBL] [Abstract][Full Text] [Related]
9. A systematic review and meta-analysis of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis: to treat or not to treat?
Dong S; Qi H; Li Y; Men P; Alifu M; Zhang Y; Li Y; Zhao R
Hepatol Int; 2021 Dec; 15(6):1356-1375. PubMed ID: 34487316
[TBL] [Abstract][Full Text] [Related]
10. Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis.
Chun HS; Choe AR; Lee M; Cho Y; Kim HY; Yoo K; Kim TH
Clin Mol Hepatol; 2021 Oct; 27(4):535-552. PubMed ID: 34130370
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies.
Qi X; De Stefano V; Li H; Dai J; Guo X; Fan D
Eur J Intern Med; 2015 Jan; 26(1):23-9. PubMed ID: 25566699
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis.
Koh JH; Liew ZH; Ng GK; Liu HT; Tam YC; De Gottardi A; Wong YJ
Dig Liver Dis; 2022 Jan; 54(1):56-62. PubMed ID: 34393072
[TBL] [Abstract][Full Text] [Related]
13. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
La Mura V; Braham S; Tosetti G; Branchi F; Bitto N; Moia M; Fracanzani AL; Colombo M; Tripodi A; Primignani M
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1146-1152.e4. PubMed ID: 29066371
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis.
Zhou H; Wu M; Yu S; Xia H; Yu W; Huang K; Chen Y
BMC Gastroenterol; 2023 Sep; 23(1):329. PubMed ID: 37749527
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy evaluation of novel oral anticoagulants in patients with cirrhosis accompanied with portal vein thrombosis: a meta-analysis].
Xu XT; Liu YW; Jin JL
Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):614-620. PubMed ID: 37400386
[No Abstract] [Full Text] [Related]
17. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis.
Amitrano L; Guardascione MA; Menchise A; Martino R; Scaglione M; Giovine S; Romano L; Balzano A
J Clin Gastroenterol; 2010 Jul; 44(6):448-51. PubMed ID: 19730112
[TBL] [Abstract][Full Text] [Related]
18. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
[TBL] [Abstract][Full Text] [Related]
19. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis.
Ai MH; Dong WG; Tan XP; Xu L; Xu C; Zhang Q; Zhang Y; Li J
Eur J Gastroenterol Hepatol; 2020 Oct; 32(10):1395-1400. PubMed ID: 32675774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
